Publication | Open Access

Piperlongumine for Enhancing Oral Bioavailability and Cytotoxicity of Docetaxel in Triple-Negative Breast Cancer

Medicinal ChemistryOral BioavailabilityOncologyPharmaceutical SciencePharmacologyBreast CancerPharmacotherapyTriple-negative Breast CancerAnti-cancer AgentCancer TreatmentMedicineDrug Discovery